Orion Corporation, Orion Pharma
Orion Corporation, Orion Pharma
Explore linked clinical trials.5 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Substudy 01A: Safety and Efficacy of Opevesostat (MK-5684)-Based Treatment Combinations or Opevesostat Alone in Participants With Metastatic Castration-resistant Prostate Cancer (mCRPC) (MK-5684-01A) | Genital Diseases, Male Urogenital Diseases, Neoplasms by Site, Prostatic Neoplasms, Castration-Resistant, Urogenital Diseases, Urogenital Neoplasms, male reproductive organ cancer, male reproductive system disorder, neoplasm, prostate cancer, prostate disorder | Recruiting | Phase 1 / Phase 2 | 2026-10-06 | NCT06353386 | |
| Trial to Study the Safety, Pharmacokinetics and Preliminary Antitumour Activity of ODM-216 in Patients With Cancer | Advanced Solid Tumors Cancer | Recruiting | Phase 1 / Phase 2 | 2026-09-24 | NCT07805252 | |
| Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer | metastatic prostate carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2026-08-14 | NCT03436485 | |
| A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours | Solid Tumours | Recruiting | Phase 1 / Phase 2 | 2026-05-08 | NCT06725758 | |
| A 2-part Phase 1/2 Open-label Trial on ODM-212 | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Thoracic Neoplasms, adenoma, bronchial neoplasm, bronchogenic carcinoma, endocrine system disorder, epithelial neoplasm, lung disorder, lung neoplasm, malignant endocrine neoplasm, malignant pancreatic neoplasm, mesothelial neoplasm, mesothelioma, neoplasm, non-small cell lung carcinoma, pancreas disorder, pancreatic neoplasm, respiratory system disorder, respiratory tract neoplasm | Recruiting | Phase 1 / Phase 2 | 2026-05-04 | NCT07563738 |